0001209191-23-045705.txt : 20230814
0001209191-23-045705.hdr.sgml : 20230814
20230814182324
ACCESSION NUMBER: 0001209191-23-045705
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230810
FILED AS OF DATE: 20230814
DATE AS OF CHANGE: 20230814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Frankenius Equity AB
CENTRAL INDEX KEY: 0001988262
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39813
FILM NUMBER: 231172541
BUSINESS ADDRESS:
STREET 1: BOX 984
CITY: BORAS
STATE: V7
ZIP: SE-501 10
BUSINESS PHONE: 46 (0) 705-27 13 50
MAIL ADDRESS:
STREET 1: BOX 984
CITY: BORAS
STATE: V7
ZIP: SE-501 10
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TriSalus Life Sciences, Inc.
CENTRAL INDEX KEY: 0001826667
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 853009869
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
BUSINESS PHONE: 415 336 8917
MAIL ADDRESS:
STREET 1: 6272 WEST 91ST AVENUE
CITY: WESTMINSTER
STATE: CO
ZIP: 80031
FORMER COMPANY:
FORMER CONFORMED NAME: MedTech Acquisition Corp
DATE OF NAME CHANGE: 20200930
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-08-10
0
0001826667
TriSalus Life Sciences, Inc.
TLSI
0001988262
Frankenius Equity AB
BOX 984
BORAS
V7
SE-501 10
SWEDEN
0
0
1
0
Common Stock
6167776
D
Series A Convertible Preferred Stock
10.00
Common Stock
230000
D
The securities reported herein were acquired by the Reporting Person in connection with the Merger (as defined in that certain Agreement and Plan of Merger, dated as of November 11, 2022, as amended, by and among the Issuer, MTAC Merger Sub, Inc., and TriSalus Operating Life Sciences, Inc.)
The Series A Convertible Preferred Stock ("Preferred Stock") is convertible, in whole or in part, into 230,000 shares of Common Stock of the Issuer (based on an initial conversion price of $10.00 per share, which is subject to adjustment upon the occurrence of certain events, the "Conversion Price") at any time, at the Reporting Person's election. The number of shares of the Issuer's Common Stock received per share of Preferred Stock upon conversion equals the sum of (A) $10.00 (as adjusted upon the occurrence of certain events) and (B) any accrued, unpaid annual dividends, divided by the Conversion Price, with cash in-lieu of fractional shares. All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027.
/s/ ULRIKA JORETEG
2023-08-14